Constanzo F, de Almeida Teixeira B, Sens P, Smaili H, Escuissato D, Ramina R
Radiol Bras. 2023; 56(2):67-74.
PMID: 37168041
PMC: 10165972.
DOI: 10.1590/0100-3984.2022.0035.
Guida L, Stumpo V, Bellomo J, van Niftrik C, Sebok M, Berhouma M
Cancers (Basel). 2022; 14(6).
PMID: 35326580
PMC: 8946242.
DOI: 10.3390/cancers14061432.
Stumpo V, Guida L, Bellomo J, van Niftrik C, Sebok M, Berhouma M
Cancers (Basel). 2022; 14(5).
PMID: 35267650
PMC: 8909110.
DOI: 10.3390/cancers14051342.
Waqar M, Lewis D, Agushi E, Gittins M, Jackson A, Coope D
Br J Radiol. 2021; 94(1125):20201450.
PMID: 34106749
PMC: 9327770.
DOI: 10.1259/bjr.20201450.
Hu Y, Chen Y, Wang J, Kang J, Shen D, Jia Z
Front Oncol. 2021; 10:593102.
PMID: 33425744
PMC: 7793903.
DOI: 10.3389/fonc.2020.593102.
Inflammation and vascular permeability correlate with growth in sporadic vestibular schwannoma.
Lewis D, Roncaroli F, Agushi E, Mosses D, Williams R, Li K
Neuro Oncol. 2018; 21(3):314-325.
PMID: 30388263
PMC: 6380424.
DOI: 10.1093/neuonc/noy177.
Early Changes in Tumor Perfusion from T1-Weighted Dynamic Contrast-Enhanced MRI following Neural Stem Cell-Mediated Therapy of Recurrent High-Grade Glioma Correlate with Overall Survival.
Sahoo P, Frankel P, Ressler J, Gutova M, Annala A, Badie B
Stem Cells Int. 2018; 2018:5312426.
PMID: 29731779
PMC: 5872616.
DOI: 10.1155/2018/5312426.
Measurement of the perfusion fraction in brain tumors with intravoxel incoherent motion MR imaging: validation with histopathological vascular density in meningiomas.
Togao O, Hiwatashi A, Yamashita K, Kikuchi K, Momosaka D, Yoshimoto K
Br J Radiol. 2018; 91(1085):20170912.
PMID: 29412000
PMC: 6190789.
DOI: 10.1259/bjr.20170912.
The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Liu X, Mangla R, Tian W, Qiu X, Li D, Walter K
J Neurooncol. 2017; 135(3):553-560.
PMID: 28889246
DOI: 10.1007/s11060-017-2602-x.
The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
Lin L, Xue Y, Duan Q, Sun B, Lin H, Huang X
Oncotarget. 2016; 7(42):69051-69059.
PMID: 27655705
PMC: 5356611.
DOI: 10.18632/oncotarget.12053.
Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen T, Cron G, Bezzina K, Perdrizet K, Torres C, Chakraborty S
AJNR Am J Neuroradiol. 2016; 37(12):2217-2223.
PMID: 27585700
PMC: 7963881.
DOI: 10.3174/ajnr.A4908.
Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.
Usinskiene J, Ulyte A, Bjornerud A, Venius J, Katsaros V, Rynkeviciene R
Neuroradiology. 2016; 58(4):339-50.
PMID: 26767528
DOI: 10.1007/s00234-016-1642-9.
Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging.
Mills S, Du Plessis D, Pal P, Thompson G, Buonacorrsi G, Soh C
AJNR Am J Neuroradiol. 2015; 37(5):811-7.
PMID: 26705318
PMC: 4817231.
DOI: 10.3174/ajnr.A4623.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Heye A, Culling R, Valdes Hernandez M, Thrippleton M, Wardlaw J
Neuroimage Clin. 2014; 6:262-74.
PMID: 25379439
PMC: 4215461.
DOI: 10.1016/j.nicl.2014.09.002.
Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters.
Bag A, Cezayirli P, Davenport J, Gaddikeri S, Fathallah-Shaykh H, Cantor A
J Neurooncol. 2014; 120(2):361-70.
PMID: 25098699
PMC: 4206596.
DOI: 10.1007/s11060-014-1560-9.
Pilot study on evaluation of any correlation between MR perfusion (Ktrans) and diffusion (apparent diffusion coefficient) parameters in brain tumors at 3 Tesla.
Chu J, Mak H, Yau K, Zhang L, Tsang J, Chan Q
Cancer Imaging. 2012; 12:1-6.
PMID: 22275724
PMC: 3266579.
DOI: 10.1102/1470-7330.2012.0001.
Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
Hu L, Eschbacher J, Dueck A, Heiserman J, Liu S, Karis J
AJNR Am J Neuroradiol. 2011; 33(1):69-76.
PMID: 22095961
PMC: 7966183.
DOI: 10.3174/ajnr.A2743.
Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers.
Awasthi R, Rathore R, Soni P, Sahoo P, Awasthi A, Husain N
Neuroradiology. 2011; 54(3):205-13.
PMID: 21541688
DOI: 10.1007/s00234-011-0874-y.
Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in glial tumor....
Server A, Graff B, Orheim T, Schellhorn T, Josefsen R, Gadmar O
Neuroradiology. 2010; 53(6):435-47.
PMID: 20857284
DOI: 10.1007/s00234-010-0770-x.